CuraSen Therapeutics
Rethinking Brain Disease
CuraSen Therapeutics was founded in 2017, is headquartered in San Carlos, United States, lists 11–50 employees, and has $60.3M in recorded funding across 2 rounds.
- Headquarters
- San Carlos, California
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- curasen.com
- Total Funding
- $60.3M
- Last Round
- $5.8M GrantOct 2023
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.
About
CuraSen Therapeutics is a privately funded biopharmaceutical company pursuing development of novel treatments for psychiatric and neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, PSP, and ALS. The company is rethinking prevailing therapeutic approaches by targeting the loss of noradrenergic signaling in the degenerating brain — specifically developing treatments that activate adrenergic receptors to restore cognitive function and brain health. CuraSen's lead program, CuraAX (CST-3056), is in Phase 1 clinical trials for neurogenic orthostatic hypotension in Parkinson's disease patients. The company is backed by investors including New Leaf Venture Partners, Longitude Capital, J&J Innovation, and the Alzheimer's Drug Discovery Foundation.
Summary
CuraSen Therapeutics is a Biotech company based in San Carlos, United States, founded in 2017. It lists 11–50 employees. It has raised $60.3M in total across 2 rounds, most recently a $5.8M Grant round in Oct 2023. Investors include Alzheimer's Drug Discovery Foundation, New Leaf Venture Partners and Alta Partners.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2023
Sign up to see all 2 events
Funding: Series A through Grant. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/curasen-therapeutics"><img src="https://indexed.vc/api/badge/company/curasen-therapeutics" alt="CuraSen Therapeutics on Indexed.vc" width="260" height="76" /></a>